Multiparametric Flow Cytometric Analysis of Inter-Patient Variation in STAT1 Phosphorylation Following Interferon Alfa Immunotherapy

Biostatistical Analysis (2nd ed.).

1986 • 5,963 citations

Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins

1994 • 5,932 citations

Clinical Cancer Research

1941 • 1,358 citations

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

2001 • 905 citations

Individuality and variation in gene expression patterns in human blood

2003 • 788 citations

Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control.

1988 • 583 citations

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

2002 • 512 citations

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry

2002 • 282 citations

Interferon Alfa Therapy for Malignant Melanoma: A Systematic Review of Randomized Controlled Trials

2002 • 258 citations

The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha.

1995 • 245 citations

Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease

1995 • 217 citations

Alterations in T cell receptor and signal transduction molecules in melanoma patients.

1995 • 192 citations

Measurement of MAP kinase activation by flow cytometry using phospho‐specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors

2001 • 179 citations

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

2002 • 173 citations

T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.

1993 • 158 citations

Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma

1995 • 138 citations

The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse

2003 • 128 citations

Detection of Intracellular Phosphorylated STAT-1 by Flow Cytometry

1999 • 127 citations

Signal transduction in the interferon system.

1998 • 124 citations

T‐cell recognition of melanoma‐associated antigens

2000 • 114 citations

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.

1996 • 111 citations

Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer

1998 • 111 citations

Detection of Intracellular Phosphorylated STAT-4 by Flow Cytometry

2001 • 103 citations

IFN-Stimulated Gene 15 Is Synergistically Activated Through Interactions Between the Myelocyte/Lymphocyte-Specific Transcription Factors, PU.1, IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein, and IFN Regulatory Factor-4: Characterization of a New Subtype of IFN-Stimulated Response Element

2002 • 102 citations

T-cell recognition of melanoma-associated antigens

2000 • 102 citations

Proliferative and cytolytic potentials of purified human tumor‐infiltrating t lymphocytes. Impaired response to mitogen‐driven stimulation despite T‐cell receptor expression

1988 • 91 citations

Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients.

1998 • 85 citations

Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines

1999 • 77 citations

Growth Hormone-induced Differential Desensitization of STAT5, ERK, and Akt Phosphorylation

2002 • 45 citations

IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA

1998 • 43 citations

Serum imbalance of cytokines in melanoma patients

2001 • 39 citations

Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10

1999 • 38 citations

Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response

2003 • 32 citations

Effects of systemic interferon-α (IFN-α) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852

1993 • 30 citations

Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.

1998 • 27 citations

Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.

2003 • 27 citations

Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.

2000 • 26 citations

Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha₂ interferon in patients with malignancies

1984 • 24 citations

IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells

2002 • 21 citations

Immunohistochemical detection of the type I interferon receptor in human fetal, adult, and neoplastic tissues.

1996 • 21 citations

The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse

2003 • 13 citations

Identification of an intragenic interferon-stimulated response element sequence of the mouse class I major histocompatibility complex H-2Kb gene.

1996 • 11 citations

lnterleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1

1996 • 11 citations